Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026, inter alia, to consider ....

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Code 524506 ISIN INE683E01017 Series EQ Dear Sir/Madam, Subject Intimation of Board meeting Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026, inter alia, to consider and approve: 1. Standalone unaudited financial results for the quarter and half year ended on September 30, 2026; 2. Any other business with the permission of chairman. In this connection, as per the Company’s Code of Conduct for Prevention of Insider Trading as framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window closure period for dealing in the Equity Shares of the Company has commenced from October 1, 2026, and will remain closed after 48 hours from declaration of financial result. This is for your information and records. Yours sincerely, For Coral Laboratories Limited Sushma Kadkade Director & CFO DIN 07791735 Place Mumbai Date November 4, 2026